ヒアルロン酸の世界市場 2023-2027

当レポートでは、ヒアルロン酸の市場規模は、2022年から2027年の間に37億1,976万米ドル拡大し、予測期間中のCAGRは7.3％で成長すると予測しています。

当レポートでは、ヒアルロン酸市場について、全体的な分析、市場規模と予測、動向、成長促進要因・課題、さらに約25のベンダーを網羅したベンダー分析を行っています。

現在の市場シナリオ、最新の動向と促進要因、市場全体の環境に関する最新の分析を提供しています。市場は、最小限のモニタリングで済む安全で安定した医薬品へのニーズ、生産設備の拡張への投資の増加、人々の健康意識の高まりによって牽引されています。

本調査では、今後数年間におけるヒアルロン酸市場の成長を促進する主な要因の一つとして、買収や合弁事業の増加を挙げています。また、技術的な進歩やスキンケア製品への応用の拡大も、市場の大きな需要につながるでしょう。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場別分析
• 市場規模 2022
• 市場の見通し 2022-2027

第4章 市場規模実績

• ヒアルロン酸の世界市場 2017-2021
• 用途別分析 2017-2021
• エンドユーザーのセグメント分析 2017-2021
• 地域別分析 2017-2021
• 国別分析 2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：用途別

• 市場セグメント
• 比較：用途別
• 皮膚フィラー：市場規模と予測 2022-2027
• 変形性関節症：市場規模と予測 2022-2027
• 眼科：市場規模と予測 2022-2027
• 膀胱尿管逆流：市場規模と予測 2022-2027
• 市場機会：用途別

第7章 市場セグメンテーション：エンドユーザー別

• 市場セグメント
• 比較：エンドユーザー別
• 製薬業界：市場規模と予測 2022-2027
• 化粧品業界：市場規模と予測 2022-2027
• 市場機会：エンドユーザー別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2022-2027
• アジア太平洋：市場規模と予測 2022-2027
• 欧州：市場規模と予測 2022-2027
• 中東・アフリカ：市場規模と予測 2022-2027
• 南米：市場規模と予測 2022-2027
• 米国：市場規模と予測 2022-2027
• カナダ：市場規模と予測 2022-2027
• 中国：市場規模と予測 2022-2027
• 韓国：市場規模と予測 2022-2027
• ドイツ：市場規模と予測 2022-2027
• 市場機会：地域別

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AbbVie Inc.
• ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke
• Anika Therapeutics Inc.
• Bausch Health Co. Inc.
• Bioxis Pharmaceutical
• Bloomage Biotechnology Corp Ltd.
• Ferring BV
• Fidia Farmaceutici Spa
• Galderma SA
• LG Chem Ltd.
• Merz Pharma GmbH and Co KGaA
• Sanofi SA
• Smith and Nephew plc
• Teva Pharmaceutical Industries Ltd.
• Zimmer Biomet Holdings Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market by Geography
• Exhibits5: Executive Summary - Chart on Market Segmentation by Application
• Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global hyaluronic acid market 2017 - 2021 ($ million)
• Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
• Exhibits20: Historic Market Size - End-users Segment 2017 - 2021 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Application - Market share 2022-2027 (%)
• Exhibits31: Data Table on Application - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Application
• Exhibits33: Data Table on Comparison by Application
• Exhibits34: Chart on Dermal fillers - Market size and forecast 2022-2027 ($ million)
• Exhibits35: Data Table on Dermal fillers - Market size and forecast 2022-2027 ($ million)
• Exhibits36: Chart on Dermal fillers - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Dermal fillers - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Osteoarthritis - Market size and forecast 2022-2027 ($ million)
• Exhibits39: Data Table on Osteoarthritis - Market size and forecast 2022-2027 ($ million)
• Exhibits40: Chart on Osteoarthritis - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Osteoarthritis - Year-over-year growth 2022-2027 (%)
• Exhibits42: Chart on Ophthalmic - Market size and forecast 2022-2027 ($ million)
• Exhibits43: Data Table on Ophthalmic - Market size and forecast 2022-2027 ($ million)
• Exhibits44: Chart on Ophthalmic - Year-over-year growth 2022-2027 (%)
• Exhibits45: Data Table on Ophthalmic - Year-over-year growth 2022-2027 (%)
• Exhibits46: Chart on Vesicoureteral reflux - Market size and forecast 2022-2027 ($ million)
• Exhibits47: Data Table on Vesicoureteral reflux - Market size and forecast 2022-2027 ($ million)
• Exhibits48: Chart on Vesicoureteral reflux - Year-over-year growth 2022-2027 (%)
• Exhibits49: Data Table on Vesicoureteral reflux - Year-over-year growth 2022-2027 (%)
• Exhibits50: Market opportunity by Application ($ million)
• Exhibits51: Data Table on Market opportunity by Application ($ million)
• Exhibits52: Chart on End-user - Market share 2022-2027 (%)
• Exhibits53: Data Table on End-user - Market share 2022-2027 (%)
• Exhibits54: Chart on Comparison by End-user
• Exhibits55: Data Table on Comparison by End-user
• Exhibits56: Chart on Pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
• Exhibits57: Data Table on Pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
• Exhibits58: Chart on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
• Exhibits59: Data Table on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
• Exhibits60: Chart on Cosmetic industry - Market size and forecast 2022-2027 ($ million)
• Exhibits61: Data Table on Cosmetic industry - Market size and forecast 2022-2027 ($ million)
• Exhibits62: Chart on Cosmetic industry - Year-over-year growth 2022-2027 (%)
• Exhibits63: Data Table on Cosmetic industry - Year-over-year growth 2022-2027 (%)
• Exhibits64: Market opportunity by End-user ($ million)
• Exhibits65: Data Table on Market opportunity by End-user ($ million)
• Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits67: Chart on Market share by geography 2022-2027 (%)
• Exhibits68: Data Table on Market share by geography 2022-2027 (%)
• Exhibits69: Chart on Geographic comparison
• Exhibits70: Data Table on Geographic comparison
• Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits75: Chart on APAC - Market size and forecast 2022-2027 ($ million)
• Exhibits76: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
• Exhibits77: Chart on APAC - Year-over-year growth 2022-2027 (%)
• Exhibits78: Data Table on APAC - Year-over-year growth 2022-2027 (%)
• Exhibits79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibits81: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits83: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
• Exhibits84: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
• Exhibits85: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
• Exhibits86: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
• Exhibits87: Chart on South America - Market size and forecast 2022-2027 ($ million)
• Exhibits88: Data Table on South America - Market size and forecast 2022-2027 ($ million)
• Exhibits89: Chart on South America - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on South America - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibits92: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibits93: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibits97: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits99: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibits100: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibits101: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits102: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits103: Chart on South Korea - Market size and forecast 2022-2027 ($ million)
• Exhibits104: Data Table on South Korea - Market size and forecast 2022-2027 ($ million)
• Exhibits105: Chart on South Korea - Year-over-year growth 2022-2027 (%)
• Exhibits106: Data Table on South Korea - Year-over-year growth 2022-2027 (%)
• Exhibits107: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits108: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibits109: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits111: Market opportunity by geography ($ million)
• Exhibits112: Data Tables on Market opportunity by geography ($ million)
• Exhibits113: Impact of drivers and challenges in 2022 and 2027
• Exhibits114: Overview on Criticality of inputs and Factors of differentiation
• Exhibits115: Overview on factors of disruption
• Exhibits116: Impact of key risks on business
• Exhibits117: Vendors covered
• Exhibits118: Matrix on vendor position and classification
• Exhibits119: AbbVie Inc. - Overview
• Exhibits120: AbbVie Inc. - Product / Service
• Exhibits121: AbbVie Inc. - Key news
• Exhibits122: AbbVie Inc. - Key offerings
• Exhibits123: ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke - Overview
• Exhibits124: ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke - Product / Service
• Exhibits125: ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke - Key news
• Exhibits126: ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke - Key offerings
• Exhibits127: Anika Therapeutics Inc. - Overview
• Exhibits128: Anika Therapeutics Inc. - Product / Service
• Exhibits129: Anika Therapeutics Inc. - Key offerings
• Exhibits130: Bausch Health Co. Inc. - Overview
• Exhibits131: Bausch Health Co. Inc. - Business segments
• Exhibits132: Bausch Health Co. Inc. - Key news
• Exhibits133: Bausch Health Co. Inc. - Key offerings
• Exhibits134: Bausch Health Co. Inc. - Segment focus
• Exhibits135: Bioxis Pharmaceutical - Overview
• Exhibits136: Bioxis Pharmaceutical - Product / Service
• Exhibits137: Bioxis Pharmaceutical - Key offerings
• Exhibits138: Bloomage Biotechnology Corp Ltd. - Overview
• Exhibits139: Bloomage Biotechnology Corp Ltd. - Product / Service
• Exhibits140: Bloomage Biotechnology Corp Ltd. - Key offerings
• Exhibits141: Ferring BV - Overview
• Exhibits142: Ferring BV - Product / Service
• Exhibits143: Ferring BV - Key offerings
• Exhibits144: Fidia Farmaceutici Spa - Overview
• Exhibits145: Fidia Farmaceutici Spa - Product / Service
• Exhibits146: Fidia Farmaceutici Spa - Key offerings
• Exhibits147: Galderma SA - Overview
• Exhibits148: Galderma SA - Product / Service
• Exhibits149: Galderma SA - Key news
• Exhibits150: Galderma SA - Key offerings
• Exhibits151: LG Chem Ltd. - Overview
• Exhibits152: LG Chem Ltd. - Business segments
• Exhibits153: LG Chem Ltd. - Key news
• Exhibits154: LG Chem Ltd. - Key offerings
• Exhibits155: LG Chem Ltd. - Segment focus
• Exhibits156: Merz Pharma GmbH and Co KGaA - Overview
• Exhibits157: Merz Pharma GmbH and Co KGaA - Product / Service
• Exhibits158: Merz Pharma GmbH and Co KGaA - Key offerings
• Exhibits159: Sanofi SA - Overview
• Exhibits160: Sanofi SA - Business segments
• Exhibits161: Sanofi SA - Key news
• Exhibits162: Sanofi SA - Key offerings
• Exhibits163: Sanofi SA - Segment focus
• Exhibits164: Smith and Nephew plc - Overview
• Exhibits165: Smith and Nephew plc - Business segments
• Exhibits166: Smith and Nephew plc - Key news
• Exhibits167: Smith and Nephew plc - Key offerings
• Exhibits168: Smith and Nephew plc - Segment focus
• Exhibits169: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits170: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits171: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits172: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits173: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits174: Zimmer Biomet Holdings Inc. - Overview
• Exhibits175: Zimmer Biomet Holdings Inc. - Business segments
• Exhibits176: Zimmer Biomet Holdings Inc. - Key news
• Exhibits177: Zimmer Biomet Holdings Inc. - Key offerings
• Exhibits178: Zimmer Biomet Holdings Inc. - Segment focus
• Exhibits179: Inclusions checklist
• Exhibits180: Exclusions checklist
• Exhibits181: Currency conversion rates for US$
• Exhibits182: Research methodology
• Exhibits183: Validation techniques employed for market sizing
• Exhibits184: Information sources
• Exhibits185: List of abbreviations

Technavio has been monitoring the hyaluronic acid market and is forecast to grow by $3719.76 mn during 2022-2027, accelerating at a CAGR of 7.3% during the forecast period. Our report on the hyaluronic acid market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the need for safe and stable drugs that require minimal monitoring., increasing investments in expanding production facilities, and increasing health consciousness among people.

Technavio's hyaluronic acid market is segmented as below:

By Application

• Dermal fillers
• Osteoarthritis
• Ophthalmic
• Vesicoureteral reflux

By End-user

• Pharmaceutical industry
• Cosmetic industry

By Geography

• North America
• APAC
• Europe
• Middle East and Africa
• South America

This study identifies the increasing acquisitions and joint ventures as one of the prime reasons driving the hyaluronic acid market growth during the next few years. Also, technological advances and expanding application of ha in skincare products. will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the hyaluronic acid market covers the following areas:

• Hyaluronic acid market sizing
• Hyaluronic acid market forecast
• Hyaluronic acid market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hyaluronic acid market vendors that include AbbVie Inc., ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke, Anika Therapeutics Inc., Bausch Health Co. Inc., Bioplus Co. Ltd., BioScience GmbH Cosmetics Trading LLC, Bioxis Pharmaceutical, Bloomage Biotechnology Corp Ltd., Ferring BV, Fidia Farmaceutici Spa, Galderma SA, Huadong Medicine Co. Ltd., Laboratoires VIVACY SAS, LG Chem Ltd., Merz Pharma GmbH and Co KGaA, Sanofi SA, Seikagaku Corp., Smith and Nephew plc, SyrHA Trading SA, Teva Pharmaceutical Industries Ltd., and Zimmer Biomet Holdings Inc. Also, the hyaluronic acid market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market by Geography
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global hyaluronic acid market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global hyaluronic acid market 2017 - 2021 ($ million)
• 4.2 Application Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
• 4.3 End-users Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - End-users Segment 2017 - 2021 ($ million)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

• 6.1 Market segments
• Exhibit 30: Chart on Application - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
• 6.2 Comparison by Application
• Exhibit 32: Chart on Comparison by Application
• Exhibit 33: Data Table on Comparison by Application
• 6.3 Dermal fillers - Market size and forecast 2022-2027
• Exhibit 34: Chart on Dermal fillers - Market size and forecast 2022-2027 ($ million)
• Exhibit 35: Data Table on Dermal fillers - Market size and forecast 2022-2027 ($ million)
• Exhibit 36: Chart on Dermal fillers - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Dermal fillers - Year-over-year growth 2022-2027 (%)
• 6.4 Osteoarthritis - Market size and forecast 2022-2027
• Exhibit 38: Chart on Osteoarthritis - Market size and forecast 2022-2027 ($ million)
• Exhibit 39: Data Table on Osteoarthritis - Market size and forecast 2022-2027 ($ million)
• Exhibit 40: Chart on Osteoarthritis - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Osteoarthritis - Year-over-year growth 2022-2027 (%)
• 6.5 Ophthalmic - Market size and forecast 2022-2027
• Exhibit 42: Chart on Ophthalmic - Market size and forecast 2022-2027 ($ million)
• Exhibit 43: Data Table on Ophthalmic - Market size and forecast 2022-2027 ($ million)
• Exhibit 44: Chart on Ophthalmic - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Ophthalmic - Year-over-year growth 2022-2027 (%)
• 6.6 Vesicoureteral reflux - Market size and forecast 2022-2027
• Exhibit 46: Chart on Vesicoureteral reflux - Market size and forecast 2022-2027 ($ million)
• Exhibit 47: Data Table on Vesicoureteral reflux - Market size and forecast 2022-2027 ($ million)
• Exhibit 48: Chart on Vesicoureteral reflux - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Vesicoureteral reflux - Year-over-year growth 2022-2027 (%)
• 6.7 Market opportunity by Application
• Exhibit 50: Market opportunity by Application ($ million)
• Exhibit 51: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 52: Chart on End-user - Market share 2022-2027 (%)
• Exhibit 53: Data Table on End-user - Market share 2022-2027 (%)
• 7.2 Comparison by End-user
• Exhibit 54: Chart on Comparison by End-user
• Exhibit 55: Data Table on Comparison by End-user
• 7.3 Pharmaceutical industry - Market size and forecast 2022-2027
• Exhibit 56: Chart on Pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
• Exhibit 57: Data Table on Pharmaceutical industry - Market size and forecast 2022-2027 ($ million)
• Exhibit 58: Chart on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
• Exhibit 59: Data Table on Pharmaceutical industry - Year-over-year growth 2022-2027 (%)
• 7.4 Cosmetic industry - Market size and forecast 2022-2027
• Exhibit 60: Chart on Cosmetic industry - Market size and forecast 2022-2027 ($ million)
• Exhibit 61: Data Table on Cosmetic industry - Market size and forecast 2022-2027 ($ million)
• Exhibit 62: Chart on Cosmetic industry - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Cosmetic industry - Year-over-year growth 2022-2027 (%)
• 7.5 Market opportunity by End-user
• Exhibit 64: Market opportunity by End-user ($ million)
• Exhibit 65: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 67: Chart on Market share by geography 2022-2027 (%)
• Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 69: Chart on Geographic comparison
• Exhibit 70: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
• Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 APAC - Market size and forecast 2022-2027
• Exhibit 75: Chart on APAC - Market size and forecast 2022-2027 ($ million)
• Exhibit 76: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
• Exhibit 77: Chart on APAC - Year-over-year growth 2022-2027 (%)
• Exhibit 78: Data Table on APAC - Year-over-year growth 2022-2027 (%)
• 9.5 Europe - Market size and forecast 2022-2027
• Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
• Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.6 Middle East and Africa - Market size and forecast 2022-2027
• Exhibit 83: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
• Exhibit 84: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
• Exhibit 85: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
• Exhibit 86: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
• 9.7 South America - Market size and forecast 2022-2027
• Exhibit 87: Chart on South America - Market size and forecast 2022-2027 ($ million)
• Exhibit 88: Data Table on South America - Market size and forecast 2022-2027 ($ million)
• Exhibit 89: Chart on South America - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on South America - Year-over-year growth 2022-2027 (%)
• 9.8 US - Market size and forecast 2022-2027
• Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
• Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.9 Canada - Market size and forecast 2022-2027
• Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
• Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.10 China - Market size and forecast 2022-2027
• Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
• Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.11 South Korea - Market size and forecast 2022-2027
• Exhibit 103: Chart on South Korea - Market size and forecast 2022-2027 ($ million)
• Exhibit 104: Data Table on South Korea - Market size and forecast 2022-2027 ($ million)
• Exhibit 105: Chart on South Korea - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on South Korea - Year-over-year growth 2022-2027 (%)
• 9.12 Germany - Market size and forecast 2022-2027
• Exhibit 107: Chart on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 108: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
• Exhibit 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.13 Market opportunity by geography
• Exhibit 111: Market opportunity by geography ($ million)
• Exhibit 112: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 113: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 115: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 116: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 117: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 118: Matrix on vendor position and classification
• 12.3 AbbVie Inc.
• Exhibit 119: AbbVie Inc. - Overview
• Exhibit 120: AbbVie Inc. - Product / Service
• Exhibit 121: AbbVie Inc. - Key news
• Exhibit 122: AbbVie Inc. - Key offerings
• 12.4 ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke
• Exhibit 123: ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke - Overview
• Exhibit 124: ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke - Product / Service
• Exhibit 125: ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke - Key news
• Exhibit 126: ABDI Ibrahim ILAC Sanayi Ve Ticaret Anonim Sirke - Key offerings
• 12.5 Anika Therapeutics Inc.
• Exhibit 127: Anika Therapeutics Inc. - Overview
• Exhibit 128: Anika Therapeutics Inc. - Product / Service
• Exhibit 129: Anika Therapeutics Inc. - Key offerings
• 12.6 Bausch Health Co. Inc.
• Exhibit 130: Bausch Health Co. Inc. - Overview
• Exhibit 131: Bausch Health Co. Inc. - Business segments
• Exhibit 132: Bausch Health Co. Inc. - Key news
• Exhibit 133: Bausch Health Co. Inc. - Key offerings
• Exhibit 134: Bausch Health Co. Inc. - Segment focus
• 12.7 Bioxis Pharmaceutical
• Exhibit 135: Bioxis Pharmaceutical - Overview
• Exhibit 136: Bioxis Pharmaceutical - Product / Service
• Exhibit 137: Bioxis Pharmaceutical - Key offerings
• 12.8 Bloomage Biotechnology Corp Ltd.
• Exhibit 138: Bloomage Biotechnology Corp Ltd. - Overview
• Exhibit 139: Bloomage Biotechnology Corp Ltd. - Product / Service
• Exhibit 140: Bloomage Biotechnology Corp Ltd. - Key offerings
• 12.9 Ferring BV
• Exhibit 141: Ferring BV - Overview
• Exhibit 142: Ferring BV - Product / Service
• Exhibit 143: Ferring BV - Key offerings
• 12.10 Fidia Farmaceutici Spa
• Exhibit 144: Fidia Farmaceutici Spa - Overview
• Exhibit 145: Fidia Farmaceutici Spa - Product / Service
• Exhibit 146: Fidia Farmaceutici Spa - Key offerings
• 12.11 Galderma SA
• Exhibit 147: Galderma SA - Overview
• Exhibit 148: Galderma SA - Product / Service
• Exhibit 149: Galderma SA - Key news
• Exhibit 150: Galderma SA - Key offerings
• 12.12 LG Chem Ltd.
• Exhibit 151: LG Chem Ltd. - Overview
• Exhibit 152: LG Chem Ltd. - Business segments
• Exhibit 153: LG Chem Ltd. - Key news
• Exhibit 154: LG Chem Ltd. - Key offerings
• Exhibit 155: LG Chem Ltd. - Segment focus
• 12.13 Merz Pharma GmbH and Co KGaA
• Exhibit 156: Merz Pharma GmbH and Co KGaA - Overview
• Exhibit 157: Merz Pharma GmbH and Co KGaA - Product / Service
• Exhibit 158: Merz Pharma GmbH and Co KGaA - Key offerings
• 12.14 Sanofi SA
• Exhibit 159: Sanofi SA - Overview
• Exhibit 160: Sanofi SA - Business segments
• Exhibit 161: Sanofi SA - Key news
• Exhibit 162: Sanofi SA - Key offerings
• Exhibit 163: Sanofi SA - Segment focus
• 12.15 Smith and Nephew plc
• Exhibit 164: Smith and Nephew plc - Overview
• Exhibit 165: Smith and Nephew plc - Business segments
• Exhibit 166: Smith and Nephew plc - Key news
• Exhibit 167: Smith and Nephew plc - Key offerings
• Exhibit 168: Smith and Nephew plc - Segment focus
• 12.16 Teva Pharmaceutical Industries Ltd.
• Exhibit 169: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 170: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 171: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 172: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 173: Teva Pharmaceutical Industries Ltd. - Segment focus
• 12.17 Zimmer Biomet Holdings Inc.
• Exhibit 174: Zimmer Biomet Holdings Inc. - Overview
• Exhibit 175: Zimmer Biomet Holdings Inc. - Business segments
• Exhibit 176: Zimmer Biomet Holdings Inc. - Key news
• Exhibit 177: Zimmer Biomet Holdings Inc. - Key offerings
• Exhibit 178: Zimmer Biomet Holdings Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 179: Inclusions checklist
• Exhibit 180: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 181: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 182: Research methodology
• Exhibit 183: Validation techniques employed for market sizing
• Exhibit 184: Information sources
• 13.5 List of abbreviations
• Exhibit 185: List of abbreviations